p53 disruption profoundly alters the response of human glioblastoma cells to DNA topoisomerase I inhibition (Q44762886)

6 December 2017

p53 disruption profoundly alters the response of human glioblastoma cells to DNA topoisomerase I inhibition (English)

1 reference

6 December 2017

1 reference

3

Timothy F Cloughesy

1 reference

6 December 2017

Yinglin Wang

1

1 reference

6 December 2017

Shaojun Zhu

series ordinal

2

1 reference

6 December 2017

Linda M Liau

series ordinal

4

1 reference

6 December 2017

Paul S Mischel

series ordinal

5

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 February 2004

1 reference

6 December 2017

1 reference

6 December 2017

23

1 reference

6 December 2017

6

1 reference

6 December 2017

1283-1290

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1207244

6 December 2017

0 references

cites work

Rapid p53 sequence analysis in primary lung cancer using an oligonucleotide probe array

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207244

A biomarker that identifies senescent human cells in culture and in aging skin in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207244

Irinotecan therapy in adults with recurrent or progressive malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207244

Role of p21 in apoptosis and senescence of human colon cancer cells treated with camptothecin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207244

The WHO classification of tumors of the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207244

Gene expression profiling identifies molecular subtypes of gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207244

Modulation of DNA damage-induced apoptosis by cell adhesion is independently mediated by p53 and c-Abl.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207244

c-Jun N-terminal kinase contributes to apoptotic synergy induced by tumor necrosis factor-related apoptosis-inducing ligand plus DNA damage in chemoresistant, p53 inactive mesothelioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207244

Activation of a p53-independent, sphingolipid-mediated cytolytic pathway in p53-negative mouse fibroblast cells treated with N-methyl-N-nitro-N-nitrosoguanidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207244

Human papilloma virus 16 E6 oncoprotein inhibits retinoic X receptor-mediated transactivation by targeting human ADA3 coactivator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207244

Interaction of c-Abl and p73alpha and their collaboration to induce apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207244

7 January 2021

Roles for p53 in growth arrest and apoptosis: putting on the brakes after genotoxic stress

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207244

7 January 2021

Epidermal growth factor receptor and Ink4a/Arf

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207244

7 January 2021

Enhancement of irinotecan (CPT-11) activity against central nervous system tumor xenografts by alkylating agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207244

7 January 2021

Perspectives on the development of a molecularly targeted agent

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207244

7 January 2021

p53 regulation of G(2) checkpoint is retinoblastoma protein dependent

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207244

7 January 2021

The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207244

7 January 2021

Therapeutic efficacy of the topoisomerase I inhibitor 7-ethyl-10-(4-[1-piperidino]-1-piperidino)-carbonyloxy-camptothecin against pediatric and adult central nervous system tumor xenografts.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207244

7 January 2021

Three distinct signalling responses by murine fibroblasts to genotoxic stress

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207244

7 January 2021

Cellular effects of CPT-11 on colon carcinoma cells: dependence on p53 and hMLH1 status

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207244

7 January 2021

5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207244

7 January 2021

Targeted molecular therapy of GBM.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207244

7 January 2021

Identification of molecular subtypes of glioblastoma by gene expression profiling.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207244

7 January 2021

Phase I Study of Weekly Intravenous Infusions of CPT-11, a New Derivative of Camptothecin, in the Treatment of Advanced Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207244

7 January 2021

Apoptotic response to camptothecin and 7-hydroxystaurosporine (UCN-01) in the 8 human breast cancer cell lines of the NCI Anticancer Drug Screen: multifactorial relationships with topoisomerase I, protein kinase C, Bcl-2, p53, MDM-2 and caspase path

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207244

7 January 2021

Rational therapeutic intervention in cancer: kinases as drug targets

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207244

7 January 2021

The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207244

7 January 2021

Activation of the Fas pathway independently of Fas ligand during apoptosis induced by camptothecin in p53 mutant human colon carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207244

7 January 2021

Smart drugs: tyrosine kinase inhibitors in cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207244

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207244

1 reference

7 January 2021

Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207244

7 January 2021

Predicting chemoresistance in human malignant glioma cells: the role of molecular genetic analyses.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207244

7 January 2021

p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207244

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1207244

1 reference

6 December 2017

1 reference